Phi Therapeutics, Inc.

New Filing

CIK: 0001778492·Biotechnology·DELAWARE·Filed: Apr 6, 2023

Total Offering

$7,655,835

Amount Sold

$4,155,831

Investors

16

First Sale

Mar 22, 2023

Offering Details

Type: Equity, Option to Acquire
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
YUG VARMA	Related Person
JUN LI	Related Person
NEIL GIUGNO	Related Person

Company

Phi Therapeutics, Inc.

1250 PETALUMA BLVD N

PETALUMA, CA, 94952

707-243-8820

SEC Filing

0001778492-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.